Skip to main content
Clinical Trials/NCT03603496
NCT03603496
Completed
Phase 4

Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers

Massachusetts General Hospital3 sites in 1 country1,416 target enrollmentSeptember 1, 2018

Overview

Phase
Phase 4
Intervention
Transitional Tobacco Care Management (TTCM)
Conditions
Smoking Cessation
Sponsor
Massachusetts General Hospital
Enrollment
1416
Locations
3
Primary Endpoint
Tobacco Abstinence, Biochemically Confirmed
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This randomized controlled trial will compare the effectiveness of two models of post-discharge tobacco cessation treatment for adult smokers admitted to 3 U.S. hospitals.

Detailed Description

This multi-site randomized controlled trial (RCT) will compare the effectiveness of two models of post-discharge tobacco cessation treatment for adult smokers who are admitted to 3 large hospital systems in 3 U.S. regions (MA, PA, TN). All patients will receive guideline-based tobacco cessation treatment delivered in hospital by each site's existing Tobacco Treatment Service that is directed by a study investigator. Patients who plan to quit smoking after hospital discharge will be randomly assigned to 1 of 2 post-discharge tobacco treatment interventions and followed at 1, 3, and 6 months. One arm uses bidirectional electronic referral (eReferral) to the state tobacco quitline. The other arm, Personalized Tobacco Care Management (PTCM), combines proactive messages delivered by automated interactive voice response (IVR) phone calls, text messaging, and/or email with health coaching provided by a hospital-based tobacco counselor. Both groups will receive at least 1 month of nicotine replacement therapy.

Registry
clinicaltrials.gov
Start Date
September 1, 2018
End Date
November 17, 2020
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Nancy A. Rigotti

Professor of Medicine

Massachusetts General Hospital

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • Current cigarette smoker (\>=1 cigarette in the week before admission and \>=1 cigarette/day when smoking at a baseline rate in the month prior to admission)
  • Admitted to a study hospital
  • Seen by hospital smoking counselor during inpatient stay
  • Plans to try to quit smoking after hospital discharge

Exclusion Criteria

  • Inability to give informed consent or participate in counseling due to serious cognitive or psychiatric disorder (e.g., dementia, psychosis)
  • Life expectancy \<12 months
  • Medical instability
  • No reliable telephone access or inability to use telephone
  • Non-English speaking
  • Pregnant, breastfeeding, to planning to become pregnant in the next 6 months.

Arms & Interventions

Transitional Tobacco Care Management (TTCM)

TTCM will provide 8 weeks of nicotine replacement therapy at hospital discharge and proactive contacts over 3 months delivered by automated IVR call. At each contact the patient is offered a return call from the hospital-based tobacco coach for counseling, medication advice, and coordination of care with the patient's outpatient health care team.

Intervention: Transitional Tobacco Care Management (TTCM)

Transitional Tobacco Care Management (TTCM)

TTCM will provide 8 weeks of nicotine replacement therapy at hospital discharge and proactive contacts over 3 months delivered by automated IVR call. At each contact the patient is offered a return call from the hospital-based tobacco coach for counseling, medication advice, and coordination of care with the patient's outpatient health care team.

Intervention: Nicotine replacement therapy

eReferral to State Tobacco Quitline (QL)

Referral from hospital to the state Quitline will be made by the research team on behalf of each enrolled patient. Quitline staff will contact patient to offer up to 5 proactive telephone calls from a tobacco coach. Patient may also be eligible for NRT sample. Feedback from the quitline will be sent back to the patient's medical chart.

Intervention: eReferral to State Tobacco Quitline (QL)

eReferral to State Tobacco Quitline (QL)

Referral from hospital to the state Quitline will be made by the research team on behalf of each enrolled patient. Quitline staff will contact patient to offer up to 5 proactive telephone calls from a tobacco coach. Patient may also be eligible for NRT sample. Feedback from the quitline will be sent back to the patient's medical chart.

Intervention: Nicotine replacement therapy

Outcomes

Primary Outcomes

Tobacco Abstinence, Biochemically Confirmed

Time Frame: 6 months after hospital discharge

Participant self-report of no use of any tobacco product (cigarettes, cigars, little cigars, pipes, smokeless tobacco product) in the past 7 days AND either a saliva sample with a cotinine concentration \<=10 ng/ml OR breath sample with a carbon monoxide concentration \<=9 ppm.

Secondary Outcomes

  • Tobacco Abstinence, Self-report(6 months after hospital discharge)
  • Engagement in Cessation Treatment(3 months after hospital discharge)
  • Self-reported Continuous Tobacco Abstinence Since Hospital Discharge(6 months follow-up)

Study Sites (3)

Loading locations...

Similar Trials